Dwoskin, L., Wooters, T., Sumithran, S., Siripurapu, K., Joyce, B., Lockman, P., … Bardo, M. (2008). N,N’-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity. The Journal of Pharmacology and Experimental Therapeutics, 326(2), 563-76. https://doi.org/10.1124/jpet.108.136630

Wooters, T., & Bardo, M. (2007). The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats. Behavioural Pharmacology, 18(7), 601-8. https://doi.org/10.1097/FBP.0b013e3282eff0d5

Wooters, T., Neugebauer, N., Rush, C., & Bardo, M. (2008). Methylphenidate enhances the abuse-related behavioral effects of nicotine in rats: intravenous self-administration, drug discrimination, and locomotor cross-sensitization. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 33(5), 1137-48. https://doi.org/10.1038/sj.npp.1301477

Wooters, T., Dwoskin, L., & Bardo, M. (2006). Age and sex differences in the locomotor effect of repeated methylphenidate in rats classified as high or low novelty responders. Psychopharmacology, 188(1), 18-27. https://doi.org/10.1007/s00213-006-0445-9

Beckmann, J., Meyer, A., Pivavarchyk, M., Horton, D., Zheng, G., Smith, A., … Dwoskin, L. (2015). r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement. Neurochemical Research, 40(10), 2121-30. https://doi.org/10.1007/s11064-015-1680-4